Cargando…
2-Deoxyglucose and Beta-Hydroxybutyrate: Metabolic Agents for Seizure Control
Current anti-seizure drugs (ASDs) are believed to reduce neuronal excitability through modulation of ion channels and transporters that regulate excitability at the synaptic level. While most patients with epilepsy respond to ASDs, many remain refractory to medical treatment but respond favorably to...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503754/ https://www.ncbi.nlm.nih.gov/pubmed/31114484 http://dx.doi.org/10.3389/fncel.2019.00172 |